Aesthetic Industry

The FDA Just Flagged a Jeuveau Instagram Reel. Aesthetics and Wellness Centers Post Similar Claims Every Day.

Dr. Kate Dee

Published on: 06/10/2026

The FDA told Evolus its Jeuveau Instagram reel was misleading. What FDA and FTC advertising rules require, and why medspa posts make the same claims.

Jeuveau FDA untitled letterEvolus Instagram misleadingfalse advertising in medicinemedspa advertising rulesBotox advertising complianceFTC health claims substantiationcompetent and reliable scientific evidenceprescription drug promotionboxed warning botulinum toxinmedspa social media compliancewellness clinic advertisingpatient testimonials advertisingmedspa marketing legal complianceneurotoxin marketing claimsMedSpa Board certification

Why "Medspa Accreditation" Barely Exists — Yet

Dr. Kate Dee

Published on: 29/09/2026

There's no license required to open a medspa in most states, and no single body enforcing medical spa law. Here's why oversight is so thin — and what's changing.

Unapproved, Untested, and Possibly Not Even Exosomes: The FDA's Warning to R3 Medical.

Dr. Kate Dee

Published on: 28/09/2026

FDA warning letter to R3 Medical: unapproved cord-derived "exosome" products, sterility gaps, and doubts they contain exosomes at all. What medspas must know.

She Wasn’t a Nurse, and It Wasn’t Botox. Now She’s Going to Federal Prison.

Dr. Kate Dee

Published on: 27/09/2026

A Massachusetts med spa owner posing as a nurse got 46 months for 2,700 counterfeit Botox and filler injections. What legitimate compliance looks like.